메뉴 건너뛰기




Volumn 168, Issue 5, 2013, Pages 675-681

Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MICRORNA; MICRORNA 1274A; MICRORNA 15A; MICRORNA 203; MICRORNA 21; MICRORNA 34A; MICRORNA 34B; MICRORNA 551B; MICRORNA 873; MICRORNA 876 3P; UNCLASSIFIED DRUG;

EID: 84877139586     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-1029     Document Type: Article
Times cited : (43)

References (42)
  • 1
    • 21244457181 scopus 로고    scopus 로고
    • BRAF mutation in thyroid cancer
    • (doi:10.1677/erc.1.0978)
    • Xing M. BRAF mutation in thyroid cancer. Endocrine-Related Cancer 2005 12 245-262. (doi:10.1677/erc.1.0978)
    • (2005) Endocrine-Related Cancer , vol.12 , pp. 245-262
    • Xing, M.1
  • 2
    • 33646442046 scopus 로고    scopus 로고
    • Increasing incidence of thyroid cancer in the United States, 1973-2002
    • (doi:10.1001/jama. 295.18.2164)
    • Davies L & Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 2006 259 2164-2167. (doi:10.1001/jama. 295.18.2164)
    • (2006) Journal of the American Medical Association , vol.259 , pp. 2164-2167
    • Davies, L.1    Welch, H.G.2
  • 3
    • 0027943619 scopus 로고
    • Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
    • (doi:10.1016/ 0002-9343(94)90321-2)
    • Mazzaferri EL & Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine 1994 97 418-428. (doi:10.1016/ 0002-9343(94)90321-2)
    • (1994) American Journal of Medicine , vol.97 , pp. 418-428
    • Mazzaferri, E.L.1    Jhiang, S.M.2
  • 5
    • 26644473629 scopus 로고    scopus 로고
    • No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan
    • (doi:10.1111/j. 1365-2265.2005.02367.x)
    • Liu RT, Chen YJ, Chou F.F., Li CL, Wu WL, Tsai PC, Huang CC & Cheng JT. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Clinical Endocrinology 2005 63 461-466. (doi:10.1111/j. 1365-2265.2005.02367.x)
    • (2005) Clinical Endocrinology , vol.63 , pp. 461-466
    • Liu, R.T.1    Chen, Y.J.2    Chou, F.F.3    Li, C.L.4    Wu, W.L.5    Tsai, P.C.6    Huang, C.C.7    Cheng, J.T.8
  • 7
    • 9144219691 scopus 로고    scopus 로고
    • Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population
    • Kim KH, Kang DW, Kim S.H., Seong IO & Kang DY. Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Medical Journal 2004 45 818-821.
    • (2004) Yonsei Medical Journal , vol.45 , pp. 818-821
    • Kim, K.H.1    Kang, D.W.2    Kim, S.H.3    Seong, I.O.4    Kang, D.Y.5
  • 8
    • 84864848268 scopus 로고    scopus 로고
    • BRAF V600E mutation in papillary thyroid carcinoma: Significant association with node metastases and extra thyroidal invasion
    • (doi:10.1007/ s12022-011-9184-5)
    • Chakraborty A, Narkar A, Mukhopadhyaya R., Kane S, D'Cruz A & Rajan MG. BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion. Endocrine Pathology 2012 23 83-93. (doi:10.1007/ s12022-011-9184-5)
    • (2012) Endocrine Pathology , vol.23 , pp. 83-93
    • Chakraborty, A.1    Narkar, A.2    Mukhopadhyaya, R.3    Kane, S.4    D'Cruz, A.5    Rajan, M.G.6
  • 9
    • 84866311243 scopus 로고    scopus 로고
    • BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: A systematic review and meta-analysis
    • (doi:10.1097/MD.0b013e31826a9c71)
    • Tufano RP, Teixeira GV, Bishop J, Carson KA & Xing M. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine 2012 91 274-286. (doi:10.1097/MD.0b013e31826a9c71)
    • (2012) Medicine , vol.91 , pp. 274-286
    • Tufano, R.P.1    Teixeira, G.V.2    Bishop, J.3    Carson, K.A.4    Xing, M.5
  • 11
    • 37349131738 scopus 로고    scopus 로고
    • BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications
    • (doi:10.1210/er.2007-0007)
    • Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocrine Reviews 2007 28 742-762. (doi:10.1210/er.2007-0007)
    • (2007) Endocrine Reviews , vol.28 , pp. 742-762
    • Xing, M.1
  • 15
    • 0347444723 scopus 로고    scopus 로고
    • MicroRNAs: Genomics, biogenesis, mechanism and function
    • (doi:10.1016/S0092-8674(04)00045-5)
    • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 2004 116 281-297. (doi:10.1016/S0092-8674(04)00045-5)
    • (2004) Cell , vol.116 , pp. 281-297
    • Bartel, D.P.1
  • 16
    • 40349100260 scopus 로고    scopus 로고
    • MicroRNAs and cancer
    • (doi:10.1111/j.1365-2796.2008.01926.x)
    • Dalmay T. MicroRNAs and cancer. Journal of Internal Medicine 2008 263 366-375. (doi:10.1111/j.1365-2796.2008.01926.x)
    • (2008) Journal of Internal Medicine , vol.263 , pp. 366-375
    • Dalmay, T.1
  • 17
    • 33750370444 scopus 로고    scopus 로고
    • MicroRNA signatures in human cancers
    • (doi:10.1038/nrc1997)
    • Calin GA & Croce CM. MicroRNA signatures in human cancers. Nature Reviews. Cancer 2006 6 857-866. (doi:10.1038/nrc1997)
    • (2006) Nature Reviews. Cancer , vol.6 , pp. 857-866
    • Calin, G.A.1    Croce, C.M.2
  • 19
    • 75549084754 scopus 로고    scopus 로고
    • Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours
    • (doi:10.1038/sj.bjc.6605493)
    • Sheu SY, Grabellus F, Schwertheim S., Worm K, Broecker-Preuss M & Schmid KW. Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. British Journal of Cancer 2010 102 376-382. (doi:10.1038/sj.bjc.6605493)
    • (2010) British Journal of Cancer , vol.102 , pp. 376-382
    • Sheu, S.Y.1    Grabellus, F.2    Schwertheim, S.3    Worm, K.4    Schmid, K.W.5
  • 22
    • 39549094091 scopus 로고    scopus 로고
    • Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using Formalin fixed paraffin embedded tissues
    • (doi:10.1007/s12022-007-0023-7)
    • Tetzlaff MT, Liu A, Xu X., Master SR, Baldwin DA, Tobias JW, Livolsi VA & Baloch ZW. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocrine Pathology 2007 18 163-173. (doi:10.1007/s12022-007-0023-7)
    • (2007) Endocrine Pathology , vol.18 , pp. 163-173
    • Tetzlaff, M.T.1    Liu, A.2    Xu, X.3    Master, S.R.4    Baldwin, D.A.5    Tobias, J.W.6    Livolsi, V.A.7    Baloch, Z.W.8
  • 23
    • 50249103246 scopus 로고    scopus 로고
    • MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma
    • (doi:10.1038/modpathol.2008.105)
    • Chen YT, Kitabayashi N, Zhou X.K., Fahey TJ III & Scognamiglio T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Modern Pathology 2008 21 1139-1146. (doi:10.1038/modpathol.2008.105)
    • (2008) Modern Pathology , vol.21 , pp. 1139-1146
    • Chen, Y.T.1    Kitabayashi, N.2    Zhou, X.K.3    Fahey III, T.J.4    Scognamiglio, T.5
  • 24
    • 80054934644 scopus 로고    scopus 로고
    • Can the microRNA signature distinguish between thyroid tumors of uncertain Malignant potential and other well-differentiated tumors of the thyroid gland?
    • (doi:10.1530/ERC-10-0283)
    • Lassalle S, Hofman V, Ilie M., Bonnetaud C, Puisségur MP, Brest P., Loubatier C, Guevara N, Bordone O, Cardinaud B et al. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? Endocrine-Related Cancer 2011 18 579-594. (doi:10.1530/ERC-10-0283)
    • (2011) Endocrine-Related Cancer , vol.18 , pp. 579-594
    • Lassalle, S.1    Hofman, V.2    Ilie, M.3    Bonnetaud, C.4    Puisségur, M.P.5    Brest, P.6    Loubatier, C.7    Guevara, N.8    Bordone, O.9    Cardinaud, B.10
  • 25
    • 77954956544 scopus 로고    scopus 로고
    • Downregulation of microRNAs directs the EMT and invasive potential of ana-plastic thyroid carcinomas
    • (doi:10.1038/onc.2010.169)
    • Braun J, Hoang-Vu C, Dralle H & Hüttelmaier S. Downregulation of microRNAs directs the EMT and invasive potential of ana-plastic thyroid carcinomas. Oncogene 2010 29 4237-4244. (doi:10.1038/onc.2010.169)
    • (2010) Oncogene , vol.29 , pp. 4237-4244
    • Braun, J.1    Hoang-Vu, C.2    Dralle, H.3    Hüttelmaier, S.4
  • 26
    • 83055176732 scopus 로고    scopus 로고
    • Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs
    • (doi:10.1245/s10434-011-1766-4)
    • Kitano M, Rahbari R, Patterson E.E., Xiong Y., Prasad NB, Wang Y, Zeiger MA & Kebebew E. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Annals of Surgical Oncology 2011 18 3443-3452. (doi:10.1245/s10434-011-1766-4)
    • (2011) Annals of Surgical Oncology , vol.18 , pp. 3443-3452
    • Kitano, M.1    Rahbari, R.2    Patterson, E.E.3    Xiong, Y.4    Prasad, N.B.5    Wang, Y.6    Zeiger, M.A.7    Kebebew, E.8
  • 27
    • 33947640956 scopus 로고    scopus 로고
    • Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model
    • (doi:10.1186/1476-4598-6-21)
    • Cahill S, Smyth P, Denning K., Flavin R, Li J, Potratz A., Guenther SM, Henfrey R. O'Leary JJ & Sheils O. Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Molecular Cancer 2007 6 21-30. (doi:10.1186/1476-4598-6-21)
    • (2007) Molecular Cancer , vol.6 , pp. 21-30
    • Cahill, S.1    Smyth, P.2    Denning, K.3    Flavin, R.4    Li, J.5    Potratz, A.6    Guenther, S.M.7    Henfrey, R.8    O'Leary, J.J.9    Sheils, O.10
  • 30
    • 0041589377 scopus 로고    scopus 로고
    • High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines
    • Xu X, Quiros RM, Gattuso P, Ain KB & Prinz RA. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Research 2003 63 4561-4567.
    • (2003) Cancer Research , vol.63 , pp. 4561-4567
    • Xu, X.1    Quiros, R.M.2    Gattuso, P.3    Ain, K.B.4    Prinz, R.A.5
  • 31
    • 84863291723 scopus 로고    scopus 로고
    • Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples
    • (doi:10.1089/thy. 2011.0313)
    • Kitano M, Rahbari R, Patterson E.E., Steinberg SM, Prasad NB, Wang Y, Zeiger MA & Kebebew E. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid 2012 22 285-291. (doi:10.1089/thy. 2011.0313)
    • (2012) Thyroid , vol.22 , pp. 285-291
    • Kitano, M.1    Rahbari, R.2    Patterson, E.E.3    Steinberg, S.M.4    Prasad, N.B.5    Wang, Y.6    Zeiger, M.A.7    Kebebew, E.8
  • 32
  • 35
    • 47049088152 scopus 로고    scopus 로고
    • Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules
    • (doi:10.1097/ PDM.0b013e31815d059d)
    • Kim SK, Kim DL, Han H.S., Kim WS, Kim SJ, Moon WJ, Oh SY & Hwang TS. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagnostic Molecular Pathology 2008 17 118-125. (doi:10.1097/ PDM.0b013e31815d059d)
    • (2008) Diagnostic Molecular Pathology , vol.17 , pp. 118-125
    • Kim, S.K.1    Kim, D.L.2    Han, H.S.3    Kim, W.S.4    Kim, S.J.5    Moon, W.J.6    Oh, S.Y.7    Hwang, T.S.8
  • 38
    • 68149162638 scopus 로고    scopus 로고
    • Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma
    • (doi:10.1055/s-0029-1215558)
    • Sheu SY, Grabellus F, Schwertheim S., Handke S, Worm K & Schmid KW. Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Hormone and Metabolic Research 2009 41 482-487. (doi:10.1055/s-0029-1215558)
    • (2009) Hormone and Metabolic Research , vol.41 , pp. 482-487
    • Sheu, S.Y.1    Grabellus, F.2    Schwertheim, S.3    Handke, S.4    Worm, K.5    Schmid, K.W.6
  • 39
    • 42249090353 scopus 로고    scopus 로고
    • MiR-21 gene expression triggered by AP-1 is sustained throughadouble-negative feedback mechanism
    • (doi:10.1016/j.jmb.2008.03.015)
    • Fujita S, Ito T, Mizutani T., Minoguchi S, Yamamichi N, Sakurai K & Iba H. miR-21 gene expression triggered by AP-1 is sustained throughadouble-negative feedback mechanism. Journal of Molecular Biology 2008 378 492-504. (doi:10.1016/j.jmb.2008.03.015)
    • (2008) Journal of Molecular Biology , vol.378 , pp. 492-504
    • Fujita, S.1    Ito, T.2    Mizutani, T.3    Minoguchi, S.4    Yamamichi, N.5    Sakurai, K.6    Iba, H.7
  • 41
    • 66449103375 scopus 로고    scopus 로고
    • Structure and regulation of the versican promoter: The versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells
    • (doi:10.1074/jbc. M807108200)
    • Domenzain-Reyna C., Hernández D, Miquel-Serra L, Docampo MJ, Badenas C, Fabra A & Bassols A. Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells. Journal of Biological Chemistry 2009 284 12306-12317. (doi:10.1074/jbc. M807108200)
    • (2009) Journal of Biological Chemistry , vol.284 , pp. 12306-12317
    • Domenzain-Reyna, C.1    Hernández, D.2    Miquel-Serra, L.3    Docampo, M.J.4    Badenas, C.5    Fabra, A.6    Bassols, A.7
  • 42
    • 27744512441 scopus 로고    scopus 로고
    • The BRAF mutation isnot associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma
    • (doi:10.1111/j.1365-2265.2005.02389.x)
    • Kim TY, Kim WB, Song J.Y., Rhee YS, Gong G, Cho YM, Kim SY, Kim S.C., Hong SJ & Shong YK. The BRAF mutation isnot associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clinical Endocrinology 2005 63 588-593. (doi:10.1111/j.1365-2265.2005.02389.x)
    • (2005) Clinical Endocrinology , vol.63 , pp. 588-593
    • Kim, T.Y.1    Kim, W.B.2    Song, J.Y.3    Rhee, Y.S.4    Gong, G.5    Cho, Y.M.6    Kim, S.Y.7    Kim, S.C.8    Hong, S.J.9    Shong, Y.K.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.